ID-IRI serves as a clinical research platform on infectious diseases and clinical microbiology
Antibiotic use in patients with Coronavirus disease 2019 (COVID-19): A snapshot ID-IRI survey” Journal of Antimicrobial Chemotherapy. (In Press)
The diagnostic utility of the Lancet and Thwaites Criteria in Tuberculous vs. Non-tuberculous Subacute Meningitis: Multicenter Analysis of 395 adult patients. BMC Infectious Diseases (At the revision stage)
A novel ID-IRI score: Development and internal validation of the multivariable community-acquired sepsis clinical risk prediction model European Journal of Clinical Microbiology & Infectious Diseases 2020;39(4):689-701
Clinicopathological profile of gastrointestinal tuberculosis in the era of immunosuppression: A multinational ID-IRI study. European Journal of Clinical Microbiology & Infectious Diseases 2020; 39: 493–500
Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection – the result of a multinational ID-IRI study. Journal of Clinical Virology 2020; 122: 104213.
Treatment of ventilator-associated pneumonia (VAP) caused by Acinetobacter: Results of prospective and multicenter ID-IRI study. European Journal of Clinical Microbiology & Infectious Diseases2020; 39: 45–52